Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$19.73 -0.58 (-2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Cost of Revenue (2016 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Cost of Revenue of $28.32 million in Q2 2026, up 36.6% from $20.73 million a year earlier and up 14.2% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Cost of Revenue (2016 - 2026) Analysis & Trends

On a TTM basis, Acadia Pharmaceuticals' Cost of Revenue came in at $100.98 million as of Jun 30, 2026, up 23.5% year-over-year; for FY2025, it came in at $89 million, up 8.7% from FY2024.

  • Annual Cost of Revenue has increased for three straight years, with a five-year compound annual growth rate of 54.2% (FY2020 to FY2025).
  • Across earlier years, Cost of Revenue came in at $81.84 million in FY2024 (+96.6%), $41.64 million in FY2023 (+309.6%), $10.17 million in FY2022 (-46.9%) and $19.14 million in FY2021 (+87.5%).
  • The Q2 2026 figure is the highest quarterly Cost of Revenue in data going back to Q2 2016.
  • On a year-over-year basis, Cost of Revenue has increased for five consecutive quarters, with growth averaging 18.3% over the last eight quarters.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 641.4% in Q4 2023, against a decline of 77.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $24.79 million (Q1 2026), $26.23 million (Q4 2025) and $21.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Acadia Pharmaceuticals 3.40 Bn -78.46 Mn 279.64 Mn 28.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.32 Mn
Mar 31, 2026 24.79 Mn
Dec 31, 2025 26.23 Mn
Sep 30, 2025 21.65 Mn
Jun 30, 2025 20.73 Mn
Mar 31, 2025 20.39 Mn
Dec 31, 2024 21.80 Mn
Sep 30, 2024 18.86 Mn
Jun 30, 2024 18.23 Mn
Mar 31, 2024 22.95 Mn
Dec 31, 2023 17.89 Mn
Sep 30, 2023 14.62 Mn
Jun 30, 2023 7.46 Mn
Mar 31, 2023 1.67 Mn
Dec 31, 2022 2.41 Mn
Sep 30, 2022 2.14 Mn
Jun 30, 2022 2.67 Mn
Mar 31, 2022 2.95 Mn
Dec 31, 2021 10.74 Mn
Sep 30, 2021 3.69 Mn
API Access

Acadia Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ACAD&period=max&api_key=YOUR_API_KEY